Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First Approval

医学 氯胺酮 患者安全 重症监护医学 安全概况 急诊医学 麻醉 梅德林 临床试验 产品(数学)
作者
Gerard Sanacora,Muhammad Ahmed,Brianne Brown,Patricia Cabrera,Teodora Doherty,Mai Himedan,David M. Kern,Lisa Lim,Oliver Lopena,Ronaldo R. Naranjo,Isaac Nuamah,Amir Sarayani,Ibrahim Turkoz,Hannah E. Bowrey
出处
期刊:American Journal of Psychiatry [American Psychiatric Association]
卷期号:182 (10): 913-921 被引量:18
标识
DOI:10.1176/appi.ajp.20240655
摘要

OBJECTIVE: The objective of this study was to comprehensively examine the real-world safety of esketamine using 58 months of postapproval data in the United States. METHODS: U.S. safety data from patient monitoring forms submitted to the esketamine Risk Evaluation and Mitigation Strategy (REMS) program and reports submitted to the Janssen U.S. Global Medical Safety (US-GMS) database were evaluated (March 5, 2019, to January 5, 2024). Patient characteristics, use and dosage patterns, adverse events of interest (actively solicited reports of sedation, dissociation, and increased blood pressure), and serious adverse events following esketamine administration were described. The incidence of suicidality and drug abuse/misuse was also evaluated. RESULTS: Most patients were 26-55 years of age (64.3%) and female (61.1%). A total of 1,486,213 outpatient treatment sessions were completed by 58,483 patients who had at least one esketamine treatment session. Sedation, dissociation, and increased blood pressure were reported in 34.7%, 41.0%, and 0.9% of sessions, respectively. Serious adverse events were reported in <0.1% and 0.18% of treatment sessions in REMS and US-GMS, respectively; suicide rates were lower than background rates; and 210 incidences of all-cause abuse/misuse were reported. CONCLUSIONS: Analysis of almost 5 years of real-world use of esketamine in the United States remains consistent with the established safety profile from clinical studies and current product labeling. No new safety signals were identified.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hzm发布了新的文献求助10
1秒前
CipherSage的应助被木木采纳,获得10
1秒前
2秒前
2秒前
2秒前
Tangyartie发布了新的文献求助10
2秒前
3秒前
无油烟发布了新的文献求助10
3秒前
大胆绿柳发布了新的文献求助10
4秒前
天天快乐的应助被fyj采纳,获得10
4秒前
4秒前
4秒前
领导范儿的应助被lr采纳,获得10
5秒前
5秒前
张张张发布了新的文献求助60
5秒前
简单的乐驹完成签到,获得积分10
5秒前
5秒前
Cynthia发布了新的文献求助10
6秒前
6秒前
XIANGYI完成签到 ,获得积分10
7秒前
melon完成签到,获得积分10
7秒前
奋斗瑶发布了新的文献求助10
7秒前
7秒前
科研小白完成签到,获得积分10
8秒前
知行合一发布了新的文献求助10
8秒前
8秒前
幸福幸福完成签到 ,获得积分10
9秒前
稳重一鸣发布了新的文献求助10
9秒前
tudou发布了新的文献求助30
10秒前
10秒前
个性向卉发布了新的文献求助10
11秒前
Lucas的应助被瓜子脸采纳,获得10
11秒前
消化天才完成签到,获得积分10
11秒前
orixero的应助被含蓄的千柳采纳,获得10
11秒前
结实的半双发布了新的文献求助100
12秒前
zz完成签到,获得积分10
12秒前
KuangNK发布了新的文献求助10
12秒前
bigpluto发布了新的文献求助10
12秒前
qiao完成签到,获得积分10
13秒前
烟花的应助被Gabriel1116采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193599
求助须知:如何正确求助?哪些是违规求助? 9579723
关于积分的说明 21867157
捐赠科研通 7793198
什么是DOI,文献DOI怎么找? 3437314
关于科研通互助平台的介绍 2560725
邀请新用户注册赠送积分活动 2484193